Arcadia Biosciences Profit Margin

Arcadia Biosciences (RKDA) currently reports a profit margin of -195.94% as of March 2026. That compares with -38.33% in the prior-year period — down 411.1% year over year. That is below the Materials sector average of 16.09%. Use the charts on this page to explore Arcadia Biosciences's profit margin history and peer comparisons.

Arcadia Biosciences's profit margin decreased from -38.33% to -195.94% — a 411.1% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Arcadia Biosciences's profit margin of -195.94% is lower than the Materials sector average of 16.09%. That is roughly 1317.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Arcadia Biosciences's current -195.94% should be judged against Materials norms (sector average: 16.09%) and against RKDA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -195.94%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Materials average is 16.09%. From there, open related valuation or income-statement pages for Arcadia Biosciences, and consider following RKDA for alerts when major investors trade the stock.